Multiple Sclerosis

World Multiple Sclerosis Day 2024: Multiple sclerosis is a complex condition that manifests itself in a variety of ways, each with its own features and course of development. Although the immune system targeting the myelin sheath is the underlying reason, research is still ongoing to determine the triggers and processes underlying this attack.

World Multiple Sclerosis Day 2024: Fatigue, dizziness, numbness in the face are early symptoms

World Multiple Sclerosis Day 2024: The complicated and frequently unpredictable disease known as multiple sclerosis can have a major negative effect on a person's quality of life. For a timely diagnosis and course of therapy, it is critical to identify symptoms early. Here are some initial signs and symptoms of multiple sclerosis.

World Multiple Sclerosis Day 2024: Effects of this disorder on patient’s brain and overall body

World Multiple Sclerosis Day 2024: Multiple sclerosis is a complex illness that affects different parts of the patient's body and brain. The effects of multiple sclerosis (MS) are varied and frequently incapacitating, ranging from neurological symptoms including vision issues and muscular spasms to cognitive and psychosocial difficulties.

World Multiple Sclerosis Day 2024: Bursting common myths and facts about this chronic autoimmune disorder

World Multiple Sclerosis Day 2024: Debunking myths and providing support to individuals impacted by multiple sclerosis require an understanding of the facts surrounding the disease. Even though multiple sclerosis (MS) comes with a lot of difficulties, advances in research and treatment have allowed many people to live active, fulfilling lives.

All about CBD oil: The hype, health benefits, and dangerous side-effects you need to know

From offsetting anxiety and depression, reducing PTSD symptoms to relieving pain, the medical world is promoting Cannabidol or CBD as the latest magical, cure-it-all potion in a bottle. But before you join the fan group and pour it into your cup of tea, let’s see how much it can really help.

Feelings of love and loss, on Mothers' Day

Multiple sclerosis is a disease that affects the central nervous system. While low incidence in tropical countries like India is a blessing, it has also meant that the support system for patients and families is sorely lacking.

Natco gets a booster dose on favorable patent ruling in US

Natco and Mylan believe that they are the first companies to have filed a substantially complete abbreviated new drug application containing a Para-IV certification for a 3 times per week Glatiramer Acetate Injection 40 mg/mL, and expect 180 days of marketing exclusivity in the US.

Sun Pharma settles patent litigation with Acorda

"The company, along with its subsidiary has entered into a settlement agreement with Acorda Therapeutics Inc to resolve the pending patent litigation involving Ampyra extended release tablets in the US," Sun Pharmaceutical Industries said in a regulatory filing.

Natco Pharma at record high; partner Mylan files ANDA

"Marketing partner in the USA, Mylan Inc has filed an abbreviated new drug application (ANDA) for a three-times-a-week generic Copaxone (glatiramer acetate injection, 40 mg/ml) and has been accepted by the US Food and Drug Administration (US FDA)," said the company in its filing.

Patent win against Teva to boost revenues: Natco Pharma

Bhaskar Narayana, Finance Director & CFO, Natco Pharma is confident of maintaining the current growth rate in terms of margins going forward.